Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-05-31
Summary
The purpose of this project was to use multi-omics technology to screen the key factors for the occurrence and development of uterine sarcoma.
Conditions
- Uterine Sarcoma
Interventions
- DIAGNOSTIC_TEST
-
Diagnostic biomarker
Diagnostic gene for uterine sarcoma
Sponsors & Collaborators
-
Shixuan Wang
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2025-11-30
- Completion
- 2025-11-30
Countries
- China
Study Locations
More Related Trials
-
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
NCT06238284 ·Status: UNKNOWN
-
Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer
NCT05336058 ·Status: COMPLETED
-
Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor
NCT04572594 ·Status: UNKNOWN
-
Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma
NCT06521684 ·Status: NOT_YET_RECRUITING
-
Metastatic Leiomyosarcoma Biomarker Protocol
NCT05653388 ·Status: RECRUITING
-
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
NCT03596593 ·Status: UNKNOWN ·Phase: NA
-
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
NCT05251883 ·Status: RECRUITING
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
NCT00250783 ·Status: COMPLETED
-
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT05208372 ·Status: UNKNOWN
-
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
NCT05737953 ·Status: RECRUITING
-
Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
NCT01258881 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)
NCT05693987 ·Status: UNKNOWN
-
Detection of G-quadruplex DNA Methylation in Cancer
NCT06537063 ·Status: WITHDRAWN
-
Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
NCT06584630 ·Status: ACTIVE_NOT_RECRUITING
-
Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas
NCT04214457 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
NCT05693974 ·Status: UNKNOWN
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT
NCT06582108 ·Status: NOT_YET_RECRUITING
-
Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas
NCT03194347 ·Status: COMPLETED
-
Microscopy Imaging of Whole-mount Stained Human Tissues
NCT05689112 ·Status: RECRUITING
-
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
NCT06341855 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
NCT05400018 ·Status: COMPLETED
-
Genomics and Prognosis in GI Cancers
NCT05767697 ·Status: RECRUITING
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
NCT07076979 ·Status: RECRUITING